Trials / Unknown
UnknownNCT05065112
Individualised Mapping in Persistent AF Ablation
Individualised MApping-Guided Ablation to Improve Outcomes in pErsistent Atrial Fibrillation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 212 (estimated)
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A clinical randomised trial to compare strategies for ablation in persistent and long-standing persistent atrial fibrillation comprising of two arms: pulmonary veins isolation (PVI) only and PVI + individualised mapping-guided ablation (Cartofinder, Biosense Webster Inc.)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pulmonary veins isolation + Cartofinder-guided ablation | The individualised mapping with Cartofinder intends to identify areas with the repetitive atrial activation patterns which are targeted with focal or linear ablation anchored on at least one end in an anatomical or electrical barrier. |
| PROCEDURE | Pulmonary veins isolation | Wide area circumferential pulmonary veins isolation |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2024-11-01
- Completion
- 2025-05-01
- First posted
- 2021-10-01
- Last updated
- 2021-10-01
Source: ClinicalTrials.gov record NCT05065112. Inclusion in this directory is not an endorsement.